Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

36.30p
   
  • Change Today:
    -0.95p
  • 52 Week High: 71.80
  • 52 Week Low: 34.50
  • Currency: UK Pounds
  • Shares Issued: 540.40m
  • Volume: 403,725
  • Market Cap: £196.17m
  • RiskGrade: 119

Financial Analysis

Select chart: EPS | Dividend | Revenue

Latest Interim/Quarterly

Period Ending Period Revenue (£m) Pre-tax (£m) EPS Dividend
30-Jun-23 Interim 81.40 6.24 1.58p n/a

Key Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-18 118.21 22.80 4.54p 14.8 n/a -15% 1.46p 2.2%
31-Dec-19 135.64 31.08 5.09p 16.5 1.4 +12% 0.54p 0.6%
31-Dec-20 129.80 13.02 5.11p 17.1 n/a 0% 1.61p 1.8%
31-Dec-21 163.21 18.16 6.39p 17.0 0.7 +25% 1.69p 1.6%
31-Dec-22 167.42 5.21 4.28p 12.4 n/a -33% 1.78p 3.4%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-23 182.43 40.12 4.48p 8.1 1.7 +5% 1.08p 0.0%
31-Dec-24 194.68 39.07 4.47p 8.1 n/a -0% 0.94p 0.0%
31-Dec-25 208.16 41.36 5.14p 7.1 0.5 +15% 0.98p 0.0%

Copyright © 2024 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest 14.76 12.38 15.57 0.54

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

Alliance Pharma Market Data

Currency UK Pounds
Share Price 36.30p
Change Today -0.95p
% Change -2.55 %
52 Week High 71.80
52 Week Low 34.50
Volume 403,725
Shares Issued 540.40m
Market Cap £196.17m
RiskGrade 119

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
82.69% above the market average82.69% above the market average82.69% above the market average82.69% above the market average82.69% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Price Trend
67.58% below the market average67.58% below the market average67.58% below the market average67.58% below the market average67.58% below the market average
12.28% above the sector average12.28% above the sector average12.28% above the sector average12.28% above the sector average12.28% above the sector average
Income
4.51% above the market average4.51% above the market average4.51% above the market average4.51% above the market average4.51% above the market average
25.00% above the sector average25.00% above the sector average25.00% above the sector average25.00% above the sector average25.00% above the sector average
Growth
88.79% below the market average88.79% below the market average88.79% below the market average88.79% below the market average88.79% below the market average
83.78% below the sector average83.78% below the sector average83.78% below the sector average83.78% below the sector average83.78% below the sector average

What The Brokers Say

Strong Buy 4
Buy 0
Neutral 3
Sell 0
Strong Sell 0
Total 7
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Final Interim
Ex-Div 22-Jun-23 22-Dec-22
Paid 18-Jul-23 19-Jan-23
Amount 1.18p 0.59p

Trades for 16-Apr-2024

Time Volume / Share Price
16:35 80,640 @ 36.30p
16:35 1 @ 36.30p
16:35 918 @ 36.30p
16:35 217 @ 36.30p
16:35 438 @ 36.30p

Alliance Pharma Key Personnel

CEO Peter Butterfield
CFO Andrew Franklin
Chair Camillo Pane

Top of Page